Please try another search
Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, and internationally. The company offers Optimer platform that enables the discovery and development of oligonucleotide binders; custom development services for oligonucleotide-based aptamer and Optimer binders; solutions to bioprocessing, diagnostic, and pharmaceutical scientists; and contract research services in the field of therapeutics. It serves pharma companies, diagnostic development companies, and research institutes. Aptamer Group plc was founded in 2008 and is headquartered in York, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
David Bunka | - | 2014 | Chief Scientific Officer, Member of the Scientific Advisory Board & Executive Director |
Stephen Hull | 69 | 2023 | Executive Chairman |
Arron Craig Tolley | 45 | 2023 | Chief Technical Officer & Director |
Dean Andrew Fielding | 57 | 2023 | Independent Non-Executive Director |
Adam Hargreaves | 44 | 2023 | Independent Non-Executive Director |
Rick Body | - | - | Scientific Advisory Board Member |
Josefin-Beate Holz | 58 | - | Scientific Advisory Board Member |
Paul Townsend | - | - | Scientific Advisory Board Member |
Shozo Fujita | - | 2021 | Scientific Advisory Board Member |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review